Amneal director exercises 34,819 RSUs into shares
Amneal Pharmaceuticals director Ted C. Nark increased his equity stake through stock-based compensation.
Rhea-AI Filing Summary
Amneal Pharmaceuticals director Ted C. Nark increased his equity stake through stock-based compensation. On May 7, 2026, he exercised 34,819 restricted stock units, receiving the same number of Class A Common Stock shares at a price of $0 per share, bringing his direct holdings to 325,848 shares.
The exercised units were part of a 34,819-unit award granted on May 6, 2025 that vested on May 7, 2026. On May 6, 2026, he also received a new grant of 19,824 restricted stock units, each representing a contingent right to one share of Class A Common Stock, with vesting tied to the company’s director vesting schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
34,819 shares exercised/converted
Exercise
3 txns
Insider
Nark Ted C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 34,819 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 34,819 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 19,824 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 19,824 contracts (Direct);
Class A Common Stock — 325,848 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.
- F3. Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
Key Figures
RSUs Exercised: 34,819 shares
Shares Held After: 325,848 shares
New RSU Grant: 19,824 units
+2 more
5 metrics
RSUs Exercised
34,819 shares
Restricted stock units converted to Class A Common Stock on May 7, 2026
Shares Held After
325,848 shares
Direct Class A Common Stock holdings following the RSU exercise
New RSU Grant
19,824 units
Restricted stock units granted on May 6, 2026 to director Ted C. Nark
RSU Conversion Price
$0.00 per unit
Stated transaction and conversion price for RSUs into Class A shares
Prior RSU Grant Size
34,819 units
Restricted stock units granted on May 6, 2025, vesting May 7, 2026
Key Terms
Restricted Stock Units, Class A Common Stock, derivative security
3 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
derivative security financial
"Transaction code M is described as an exercise or conversion of a derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did Amneal (AMRX) director Ted C. Nark report in this Form 4?
Ted C. Nark reported stock-based compensation activity, not open-market trading. He exercised 34,819 restricted stock units into an equal number of Amneal Class A shares and received a new award of 19,824 restricted stock units tied to future vesting.
What are the key details of the new restricted stock unit grant at Amneal (AMRX)?
On May 6, 2026, Ted C. Nark received 19,824 restricted stock units, each representing a contingent right to one Amneal Class A share. Vesting follows the company’s director vesting formula, based on the timing of annual stockholder meetings and the grant anniversary.
How did the previously granted Amneal (AMRX) RSUs vest for Ted C. Nark?
A prior award of 34,819 restricted stock units granted on May 6, 2025 vested on May 7, 2026. Upon vesting, these units were settled in 34,819 shares of Amneal Class A Common Stock, consistent with the company’s policy that each unit converts into one share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
